Parsia A Vagefi

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Parsia A Vagefi
    Division of Transplantation, University of California, San Francisco, CA 94143, USA
    J Gastrointest Cancer 41:217-20. 2010
  2. pmc Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review
    Parsia A Vagefi
    Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    J Gastrointest Surg 15:209-14. 2011
  3. doi Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    Arch Surg 146:1052-9. 2011
  4. pmc Ex vivo split-liver transplantation: the true right/left split
    Parsia A Vagefi
    Division of Transplant Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    HPB (Oxford) 16:267-74. 2014
  5. doi Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Liver Transpl 18:160-5. 2012
  6. doi Multiple listings as a reflection of geographic disparity in liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA Electronic address
    J Am Coll Surg 219:496-504. 2014
  7. pmc Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA
    Liver Transpl 21:187-94. 2015
  8. doi Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans
    Parsia A Vagefi
    Department of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
    Transpl Int 26:471-6. 2013
  9. doi Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction
    Todd V Brennan
    Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Clin Transplant 29:34-43. 2015
  10. doi Successful long-term management of invasive cerebral fungal infection following liver transplantation
    Madhukar S Patel
    Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
    Mycoses 58:181-6. 2015

Collaborators

Detail Information

Publications10

  1. pmc Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Parsia A Vagefi
    Division of Transplantation, University of California, San Francisco, CA 94143, USA
    J Gastrointest Cancer 41:217-20. 2010
    ..We present a patient with HCC who underwent treatment with sorafenib, which resulted in a remarkable reduction in tumor burden to allow for liver transplant listing...
  2. pmc Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review
    Parsia A Vagefi
    Division of Transplant Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    J Gastrointest Surg 15:209-14. 2011
    ..The optimal surgical management of symptomatic hepatic hemangiomas remains controversial, with resection, enucleation, and both deceased donor and living donor liver transplantation having been reported...
  3. doi Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA
    Arch Surg 146:1052-9. 2011
    ..Split liver transplantation (SLT) allows for expansion of the deceased donor pool...
  4. pmc Ex vivo split-liver transplantation: the true right/left split
    Parsia A Vagefi
    Division of Transplant Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
    HPB (Oxford) 16:267-74. 2014
    ..Successful left lateral segment (sectionectomy) and right trisegmentectomy (trisectionectomy) split-liver transplantation (SLT) have been achieved. However, there are few reports of the use of true right/left splitting in SLT...
  5. doi Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Liver Transpl 18:160-5. 2012
    ..These differences can be hypothesized to be driven in part by the relative availability of LDLT versus DDLT at both the patient level and the DSA level...
  6. doi Multiple listings as a reflection of geographic disparity in liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA Electronic address
    J Am Coll Surg 219:496-504. 2014
    ..This study sought to examine Model for End-Stage Liver Disease-era multiply listed (ML) LT candidate (ie, candidates who list at 2 or more LT centers to receive a liver transplant)...
  7. pmc Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation
    Parsia A Vagefi
    Division of Transplant Surgery, Department of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA
    Liver Transpl 21:187-94. 2015
    ..009) after adjustments for clinical characteristics. In conclusion, the consideration of certain donor factors may reduce the cumulative incidence of posttransplant HCC recurrence and thus improve long-term survival after LT...
  8. doi Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans
    Parsia A Vagefi
    Department of Surgery, Massachusetts General Hospital Harvard Medical School, Boston, MA, USA
    Transpl Int 26:471-6. 2013
    ....
  9. doi Renal outcomes of simultaneous liver-kidney transplantation compared to liver transplant alone for candidates with renal dysfunction
    Todd V Brennan
    Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Clin Transplant 29:34-43. 2015
    ..63) and prevalence of stage 4 or 5 chronic kidney disease (CKD; 5.9% vs. 6.8%, p = 0.11) were comparable. Our series provides little evidence that RD-SLKT would have yielded substantial short-term survival benefit to RD-LTA recipients. ..
  10. doi Successful long-term management of invasive cerebral fungal infection following liver transplantation
    Madhukar S Patel
    Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
    Mycoses 58:181-6. 2015
    ..In particular, we highlight the issues around therapeutic monitoring and discontinuation of therapy. ..